Clinical Social Workers in Mansfield, OH Accepting Medicare
89 Clinical Social Workers found. Showing 81 - 89
 Mr. David Warren Aiken, MSW, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 741 Scholl Rd, Mansfield, OH 44907 Phone: 419-756-1717 |
Thomas Edward Burkhardt, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 741 Scholl Rd, Mansfield, OH 44907 Phone: 419-774-6866 Fax: 419-756-2594 |
 Mrs. Linda Varnett Emerson, L.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1066 Lexington Ave, Mansfield, OH 44907 Phone: 419-526-5523 |
Christy Robin Barnes, MSW, LSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 721 Deborah Ct, Mansfield, OH 44904 Phone: 419-589-5511 Fax: 419-589-4656 |
Laurie Ann Korbas, MSW, LISW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 741 Scholl Rd, Mansfield, OH 44907 Phone: 419-756-1717 |
Ms. Toby Lynn Reed, MSW, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1814 Victoria Ct, Mansfield, OH 44906 Phone: 419-564-9665 |
Josselyn West, LSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 680 Park Ave W, Mansfield, OH 44906 Phone: 419-528-5993 Fax: 560-567-5486 |
Ms. Ladonna Pauline Gleisinger, LISW-S, BCPC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1456 Park Ave W Ste N, Mansfield, OH 44906 Phone: 419-529-4602 |
Adelia Bernice Olson, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1620 Friday Ln, Mansfield, OH 44906 Phone: 419-529-4291 Fax: 419-529-4291 |
News Archive
Two new sources of soybean may replace fish meal in weanling pig diets
Two new sources of soybean meal are capturing attention throughout the country. University of Illinois research indicates that fermented soybean meal and enzyme-treated soybean meal may replace fish meal in weanling pig diets.
BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
DATIS, NPS MedicineWise partner to deliver face-to-face educational visits to GPs across South Australia
A new three-year contract launched in Adelaide today will see the Drug and Therapeutics Information Service (DATIS) based at the Repatriation General Hospital continue to deliver NPS MedicineWise educational visiting programs to general practitioners (GPs) across South Australia.
Phase 1/2 clinical trial of TRC105 therapy initiated for patients with castrate-resistant prostate cancer
TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that the National Cancer Institute has initiated a Phase 1/2 clinical trial of TRC105 therapy for patients with castrate-resistant prostate cancer.
› Verified 2 days ago
Counselors
Clinical Social Workers
Pharmacists
Dentists
Occupational Therapists
Psychologists